These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. DEA reschedules hydrocodone combination products as schedule II. J Mich Dent Assoc; 2014 Oct; 96(10):11. PubMed ID: 25647867 [No Abstract] [Full Text] [Related]
11. The US Opioid Crisis: Current Federal and State Legal Issues. Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113 [TBL] [Abstract][Full Text] [Related]
12. An empty toolbox: hydrocodone to schedule II. Berger BJ Ann Emerg Med; 2014 Dec; 64(6):19A-21A. PubMed ID: 25606604 [No Abstract] [Full Text] [Related]
13. Recent developments toward the safer use of opioids, with a focus on hydrocodone. Covvey JR Res Social Adm Pharm; 2015; 11(6):901-8. PubMed ID: 25769501 [TBL] [Abstract][Full Text] [Related]
14. FDA panel recommends tighter rules for prescribing opioids. McCarthy M BMJ; 2013 Feb; 346():f1012. PubMed ID: 23412738 [No Abstract] [Full Text] [Related]
15. FDA advisers support rescheduling of hydrocodone products. Traynor K Am J Health Syst Pharm; 2013 Mar; 70(5):383-4. PubMed ID: 23413158 [No Abstract] [Full Text] [Related]
16. Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS). Nelson LS; Perrone J JAMA; 2012 Aug; 308(5):457-8. PubMed ID: 22851109 [No Abstract] [Full Text] [Related]
17. The FDA's Approach to the Prescription Opioid Problem. Woodcock J; Throckmorton DC Clin Pharmacol Ther; 2018 Jun; 103(6):954-955. PubMed ID: 29570773 [TBL] [Abstract][Full Text] [Related]
19. Zohydro approval by food and drug administration: controversial or frightening? Manchikanti L; Atluri S; Candido KD; Boswell MV; Simopoulos TT; Grider JS; Falco FJ; Hirsch JA Pain Physician; 2014; 17(4):E437-50. PubMed ID: 25054396 [TBL] [Abstract][Full Text] [Related]
20. Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential. Hale ME; Ma Y; Malamut R J Opioid Manag; 2016; 12(2):139-47. PubMed ID: 27194199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]